Search details
1.
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
Cell
; 175(7): 1731-1743.e13, 2018 12 13.
Article
in English
| MEDLINE | ID: mdl-30503213
2.
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
Cancer
; 2024 Jan 31.
Article
in English
| MEDLINE | ID: mdl-38294959
3.
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Oncologist
; 28(7): 644-e564, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37186063
4.
Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
Clin Genet
; 103(1): 119-124, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36089892
5.
A unique window of opportunity for practical reform of cancer clinical trials.
Cancer
; 127(16): 2855-2860, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-33849079
6.
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
BMC Cancer
; 21(1): 1094, 2021 Oct 11.
Article
in English
| MEDLINE | ID: mdl-34635061
7.
Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
Int J Cancer
; 147(11): 3236-3249, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32478869
8.
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
Cancer
; 126(13): 3021-3030, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32320048
9.
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.
Cancer
; 125(3): 406-415, 2019 02 01.
Article
in English
| MEDLINE | ID: mdl-30341983
10.
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.
Oncologist
; 24(9): e930-e942, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30833489
11.
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors.
Invest New Drugs
; 37(1): 87-97, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29781056
12.
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Natl Compr Canc Netw
; 17(5): 469-477, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-31085759
13.
What if Acupuncture Were Covered by Insurance for Pain Management? A Cross-Sectional Study of Cancer Patients at One Academic Center and 11 Community Hospitals.
Pain Med
; 20(10): 2060-2068, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-31329938
14.
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.
Mol Ther
; 26(5): 1198-1205, 2018 05 02.
Article
in English
| MEDLINE | ID: mdl-29550074
15.
The association between fatigue and pain symptoms and decreased physical activity after cancer.
Support Care Cancer
; 26(10): 3423-3430, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-29675547
16.
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Cancer
; 123(21): 4244-4251, 2017 Nov 01.
Article
in English
| MEDLINE | ID: mdl-28678434
17.
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.
Invest New Drugs
; 35(5): 576-588, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28424891
18.
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.
BMC Cancer
; 17(1): 173, 2017 03 06.
Article
in English
| MEDLINE | ID: mdl-28264648
19.
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma.
Cancer
; 122(15): 2350-5, 2016 08 01.
Article
in English
| MEDLINE | ID: mdl-27197056
20.
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer
; 122(23): 3641-3649, 2016 Dec 01.
Article
in English
| MEDLINE | ID: mdl-27648727